Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The studies were not designed to show how or why GLP-1 use might affect cancer treatment
Administered as a once-weekly subcutaneous injection, tirzepatide is typically initiated at 2.5 mg and increased by 2.5 mg every 4 weeks to a target dose of 5-15 mg as tolerated
Although approved for type 2 diabetes, Ozempic became widely associated with the broader GLP-1 boom because of its impact on body weight and metabolic outcomes
In oncology, although Keytruda maintained a 4% year-over-year increase, it began to decline quarter-over-quarter
US$ 29.84
US$ 24.84
US$ 20.64
US$ 21.16
